MTC Insights

pregnant woman

Tailoring Thyroid Cancer Treatment for Pregnant Women

During the early stages of most clinical trials, medical researchers tend to recruit healthy adult males with no comorbidities. This is because they generally represent the safest segment of the population for experimental therapies to be tested on. In contrast, women of reproductive age tend to be the last segment of the population to be…


Calcitonin: From Multipurpose Drug to Biomarker for MTC

Previous to its widespread use as a cancer biomarker, including its role in raising suspicion of medullary thyroid cancer (MTC), calcitonin had an interesting history.  In the Journal of Musculoskeletal Neuronal Interactions, Srinivasan and colleagues detailed the early history of calcitonin. It was first discovered as a blood-calcium lowering hormone in 1961. It has been…

Next post in MTC Insights